DexCom (NASDAQ:DXCM – Get Free Report) had its target price upped by equities research analysts at Piper Sandler from $150.00 to $160.00 in a research note issued to investors on Friday, FlyOnTheWall reports. Piper Sandler’s target price suggests a potential upside of 20.86% from the stock’s previous close. A number of other equities analysts also […]
DexCom (NASDAQ:DXCM – Get Free Report) had its price objective boosted by analysts at Robert W. Baird from $145.00 to $153.00 in a report issued on Friday, FlyOnTheWall reports. Robert W. Baird’s target price indicates a potential upside of 15.58% from the stock’s current price. Several other research analysts have also recently issued reports on […]
DexCom (NASDAQ:DXCM – Get Free Report) released its quarterly earnings results on Thursday. The medical device company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.12, Briefing.com reports. The business had revenue of $871.30 million during the quarter, compared to analysts’ expectations of $841.16 million. DexCom had a […]
NorthRock Partners LLC lessened its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.4% in the first quarter, HoldingsChannel reports. The fund owned 3,538 shares of the medical device company’s stock after selling 499 shares during the quarter. NorthRock Partners LLC’s holdings in DexCom were worth $411,000 as of its most recent SEC filing. […]
DexCom (NASDAQ:DXCM – Free Report) had its price target lifted by Robert W. Baird from $145.00 to $153.00 in a research note issued to investors on Friday, FlyOnTheWall reports. DXCM has been the subject of a number of other research reports. Citigroup raised their target price on shares of DexCom from $146.00 to $150.00 in […]